VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 739 filers reported holding VANECK VECTORS ETF TR in Q2 2023. The put-call ratio across all filers is 0.48 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $13,840,671 | -35.9% | 514,332 | -28.3% | 0.04% | -64.3% |
Q2 2023 | $21,602,717 | -8.7% | 717,460 | -1.9% | 0.11% | +124.0% |
Q1 2023 | $23,662,731 | +13.4% | 731,460 | +0.5% | 0.05% | +6.4% |
Q4 2022 | $20,860,439 | +41.1% | 727,859 | +18.7% | 0.05% | +20.5% |
Q3 2022 | $14,786,000 | -22.7% | 613,017 | -12.2% | 0.04% | -20.4% |
Q2 2022 | $19,124,000 | -27.2% | 698,484 | +1.9% | 0.05% | -14.0% |
Q1 2022 | $26,287,000 | +35.2% | 685,456 | +12.9% | 0.06% | +35.7% |
Q4 2021 | $19,439,000 | +13.2% | 606,915 | +4.1% | 0.04% | 0.0% |
Q3 2021 | $17,178,000 | -34.7% | 582,892 | -24.7% | 0.04% | -38.2% |
Q2 2021 | $26,293,000 | +18.8% | 773,768 | +13.6% | 0.07% | -5.6% |
Q1 2021 | $22,135,000 | +60.6% | 681,092 | +78.0% | 0.07% | +60.0% |
Q4 2020 | $13,783,000 | -14.8% | 382,653 | -7.4% | 0.04% | -28.6% |
Q3 2020 | $16,179,000 | -19.2% | 413,139 | -24.4% | 0.06% | -30.8% |
Q2 2020 | $20,034,000 | +60.8% | 546,181 | +1.0% | 0.09% | +28.2% |
Q1 2020 | $12,460,000 | -32.7% | 540,814 | -14.5% | 0.07% | -15.5% |
Q4 2019 | $18,522,000 | +11.1% | 632,588 | +1.4% | 0.08% | -3.4% |
Q3 2019 | $16,671,000 | +6.0% | 624,133 | +1.5% | 0.09% | +1.2% |
Q2 2019 | $15,723,000 | +18.5% | 615,125 | +3.9% | 0.09% | +24.6% |
Q1 2019 | $13,272,000 | +36.1% | 591,980 | +28.0% | 0.07% | +16.9% |
Q4 2018 | $9,751,000 | +68.0% | 462,337 | +47.5% | 0.06% | +110.7% |
Q3 2018 | $5,804,000 | -7.1% | 313,356 | +11.9% | 0.03% | -20.0% |
Q2 2018 | $6,250,000 | +1793.9% | 280,123 | +1767.5% | 0.04% | +1650.0% |
Q1 2018 | $330,000 | -72.2% | 15,000 | -70.7% | 0.00% | -75.0% |
Q4 2017 | $1,189,000 | +106.1% | 51,137 | +103.4% | 0.01% | +100.0% |
Q3 2017 | $577,000 | +4.0% | 25,137 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $555,000 | -72.1% | 25,137 | -66.5% | 0.00% | -78.9% |
Q3 2016 | $1,986,000 | -16.1% | 75,146 | -12.0% | 0.02% | -17.4% |
Q2 2016 | $2,367,000 | – | 85,406 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |